Shijiazhuang Yuanjia Biotechnology Co. Ltd. to commercialize Peptonic Medical’s VagiVital® in China
Stockholm, 25 July, 2019 – Peptonic Medical (publ) (“Peptonic” or “Company”) today announced that it has entered an agreement with Shijiazhuang Yuanjia Biotechnology Co. Ltd. (“Yuanjia Bio”) concerning the registration, marketing, sales and distribution of VagiVital® in the People’s Republic of China (PRC). Under the agreement, Yuanjia Bio is granted the exclusive commercial rights to VagiVital® in PRC. In return, Yuanjia Bio has committed to annual minimum purchase volumes of VagiVital® and to bear all costs of registration and the commercialization of the product. Upon signature of the